Application of monoterpenoids and their derivatives for treatment of neurodegenerative disorders

Original language	English
Pages (from-to)	5327-5346
Number of pages	20
Journal	Current Medicinal Chemistry
Volume	25
Issue number	39
DOIs	https://doi.org/10.2174/0929867324666170112101837
Publication status	Published - 1 Jan 2018

Acetylcholinesterase inhibitors, Alzheimer's disease, Cannabinoids, Huntington’s disease, Monoterpenes, Monoterpenoids, Neuroprotective activity, Parkinson’s disease, Humans, Neuroprotective Agents/chemistry, Brain Ischemia/metabolism, Animals, Neurodegenerative Diseases/drug therapy, Cholinesterase Inhibitors/chemistry, Receptor, Cannabinoid, CB2/antagonists & inhibitors, Monoterpenes/chemistry, Acetylcholinesterase/chemistry, Receptor, Cannabinoid, CB1/antagonists & inhibitors

ID: 18067049